- Report
- July 2023
- 146 Pages
North America
From €1322EUR$1,500USD£1,150GBP
- Report
- February 2022
- 59 Pages
Global
From €1763EUR$2,000USD£1,534GBP
- Report
- January 2024
- 95 Pages
Global
From €3500EUR$4,254USD£3,152GBP
- Report
- July 2023
- 97 Pages
Global
From €3500EUR$4,254USD£3,152GBP
- Report
- May 2023
- 93 Pages
Global
From €3500EUR$4,254USD£3,152GBP
- Report
- March 2024
- 132 Pages
Global
From €837EUR$950USD£729GBP
- Report
- March 2024
- 132 Pages
Global
From €837EUR$950USD£729GBP
- Book
- June 2018
- 496 Pages
The sedative market is a subset of the Central Nervous System (CNS) drugs market. Sedatives are drugs used to induce relaxation, reduce anxiety, and promote sleep. They are commonly prescribed to treat insomnia, anxiety disorders, and seizures. Sedatives can be classified into two main categories: benzodiazepines and non-benzodiazepines. Benzodiazepines are the most commonly prescribed sedatives, and are used to treat a variety of conditions, including anxiety, insomnia, and seizures. Non-benzodiazepines are newer drugs that are used to treat insomnia and anxiety.
Some companies in the sedative market include Pfizer, GlaxoSmithKline, Sanofi, Merck, and Novartis. Show Less Read more